Moramide intermediate (β-Methyl-α,α-diphenyl-4-morpholinebutanoic acid, on INCB Yellow List as 2-methyl-3-morpholino-1,1-diphenylpropane carboxylic acid) is a moramide precursor scheduled by UN Single Convention on Narcotic Drugs.

Moramide intermediate
Clinical data
Trade namesβ-Methyl-α,α-diphenyl-4-morpholinebutanoic acid
Other names4-Morpholinebutanoic acid, β-methyl-α,α-diphenyl-, moramide intermediate
Routes of
administration
N/A
ATC code
  • none
Legal status
Legal status
Identifiers
  • 3-Methyl-4-morpholin-4-yl-2,2-diphenylbutanoic acid
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC21H25NO3
Molar mass339.435 g·mol−1
3D model (JSmol)
  • O=C(O)C(c1ccccc1)(c2ccccc2)C(C)CN3CCOCC3
  • InChI=1S/C21H25NO3/c1-17(16-22-12-14-25-15-13-22)21(20(23)24,18-8-4-2-5-9-18)19-10-6-3-7-11-19/h2-11,17H,12-16H2,1H3,(H,23,24)
  • Key:AWLNVHVUYACOMZ-UHFFFAOYSA-N

In the United States, moramide intermediate is designated as a Schedule II controlled substance,[2] and has an ACSCN of 9802. The 2014 annual manufacturing quota was nil.[3]

In Australia, moramide intermediate is listed as a Schedule 9 (Prohibited Substance)[4]

See also

edit

References

edit
  1. ^ Anvisa (2023-03-31). "RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial" [Collegiate Board Resolution No. 784 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control] (in Brazilian Portuguese). Diário Oficial da União (published 2023-04-04). Archived from the original on 2023-08-03. Retrieved 2023-08-16.
  2. ^ Controlled Substances - by DEA Drug Code Number
  3. ^ "DEA Diversion Control Division".
  4. ^ "Therapeutic Goods (Poisons Standard—February 2024) Instrument 2024". Federal Register of Legislation. 23 January 2024. Retrieved 18 June 2024.